FDA Inspection 645552 — Lydie L. Hazan, M.D.

Lydie L. Hazan, M.D. — FEI 3005993434

The FDA completed an inspection of Lydie L. Hazan, M.D. on February 11, 2010 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 11, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent
766621 CFR 50.20Understandable language